| Identification | Back Directory | [Name]
Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4'-(1H-imidazol-5-yl)[1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester | [CAS]
1256385-55-3 | [Synonyms]
Methyl ((S)-1-((S)-2-(5-(4'-(1H-Imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4'-(1H-imidazol-5-yl)[1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester | [Molecular Formula]
C29H32N6O3 | [MDL Number]
MFCD34470017 | [MOL File]
1256385-55-3.mol | [Molecular Weight]
512.6 |
| Hazard Information | Back Directory | [Uses]
Daclatasvir Impurity C is the impurity of Daclatasvir. Daclatasvir is a potent HCV NS5A protein inhibitor[1]. | [References]
[1] Naz A , et al. Simultaneous analysis of daclatasvir with its three organic impurities: Application in stability studies, pharmaceutical and serum samples[J]. Microchemical Journal, 2019. |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|